Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen

BACKGROUND: Chronic hepatitis B virus (HBV) infection is complicated by cirrhosis and liver cancer. In Thailand, 6-7 % of adults are chronically infected with HBV. The risk of mother-to-child transmission (MTCT) of HBV has been estimated to be about 12 % when mothers have a high hepatitis B viral lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jourdain, Gonzague, Ngo-Giang-Huong, Nicole, Cressey, Tim R., Hua, Lei, Harrison, Linda, Tierney, Camlin, Salvadori, Nicolas, Decker, Luc, Traisathit, Patrinee, Sirirungsi, Wasna, Khamduang, Woottichai, Bowonwatanuwong, Chureeratana, Puthanakit, Thanyawee, Siberry, George K., Watts, Diane Heather, Murphy, Trudy V., Achalapong, Jullapong, Hongsiriwon, Suchat, Klinbuayaem, Virat, Thongsawat, Satawat, Chung, Raymond T., Pol, Stanislas, Chotivanich, Nantasak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977630/
https://www.ncbi.nlm.nih.gov/pubmed/27506549
http://dx.doi.org/10.1186/s12879-016-1734-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977630/
https://www.ncbi.nlm.nih.gov/pubmed/27506549
http://dx.doi.org/10.1186/s12879-016-1734-5

Ejemplares similares